15 November 2022: ERRATUM 
Errate: Hypoprothrombinemia During Cefmetazole Treatment: A Case Report
Yuichiro Haba1*, Hikaru Akizuki2, Naoyuki Hashiguchi2, Toshio Naito1DOI: 10.12659/AJCR.938954
Am J Case Rep 2022; 23:e938954
Abstract
ABSTRACT: The authors contacted the journal with the following corrections to the published article: 1. Table 1. PT-INR at 6th hospital day. 2.46 is incorrect; Correct: 2.47. 2. Table 2. Line 5, at Purpose of use of CMZ. NA is incorrect; Correct: Infection secondary to Pneumothorax. 3. Table 2. Line 11, at PT-INR, 2.46 is incorrect; Correct: 2.47. 4. References No. 22 and No. 23 are reversed. The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. Reference: Yuichiro Haba, Hikaru Akizuki, Naoyuki Hashiguchi, Toshio Naito. Hypoprothrombinemia During Cefmetazole Treatment: A Case Report. Am J Case Rep. 2022; 23: e936712. DOI: 10.12659/AJCR.936712
Keywords: Humans, Cefmetazole, cephalosporins, Hypoprothrombinemias, Cephamycins
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953836
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.953506
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.953059
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.952994
Most Viewed Current Articles
07 Dec 2021 : Case report 
22,773,551
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report 
179,044
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
122,928
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
67,407
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133